EPIRUS BIOPHARMACEUTICALS Trademark

Trademark Overview

On Monday, January 7, 2013, a trademark application was filed for EPIRUS BIOPHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the EPIRUS BIOPHARMACEUTICALS trademark a serial number of 85817297. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 4, 2020. This trademark is owned by EPIRUS Biopharmaceuticals, Inc. The EPIRUS BIOPHARMACEUTICALS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical preparations, namely, generic versions, biosimilars, and follow on biologics used for the treatment of multiple disorders, namely, oncology, respiratory disorders, gastrointestinal disorders and rheumatic conditions
epirus biopharmaceuticals

General Information

Serial Number85817297
Word MarkEPIRUS BIOPHARMACEUTICALS
Filing DateMonday, January 7, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 4, 2020
Registration Number4522926
Registration DateTuesday, April 29, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2013

Trademark Statements

Disclaimer with Predetermined Text"BIOPHARMACEUTICALS"
Goods and ServicesResearch and development of pharmaceutical preparations, namely, generic versions, biosimilars, and follow on biologics used for the treatment of multiple disorders, namely, oncology, respiratory disorders, gastrointestinal disorders and rheumatic conditions
Pseudo MarkEPIRUS BIO PHARMACEUTICALS

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 4, 2020
Primary Code042
First Use Anywhere DateTuesday, January 1, 2013
First Use In Commerce DateTuesday, January 1, 2013

Trademark Owner History

Party NameEPIRUS Biopharmaceuticals, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBoston, MA 02199
Party NameEPIRUS Biopharmaceuticals, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02199
Party NameEPIRUS Biopharmaceuticals, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02199

Trademark Events

Event DateEvent Description
Friday, December 4, 2020CANCELLED SEC. 8 (6-YR)
Monday, April 29, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, April 29, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, March 25, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, March 22, 2014LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, March 20, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 20, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, March 19, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2014EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2014SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, March 11, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2014NON-FINAL ACTION E-MAILED
Tuesday, March 11, 2014SU - NON-FINAL ACTION - WRITTEN
Tuesday, February 18, 2014STATEMENT OF USE PROCESSING COMPLETE
Monday, January 20, 2014USE AMENDMENT FILED
Monday, February 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 20, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, July 23, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 22, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, April 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 16, 2013EXAMINER'S AMENDMENT ENTERED
Friday, April 12, 2013ASSIGNED TO LIE
Friday, April 12, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, April 12, 2013EXAMINERS AMENDMENT E-MAILED
Friday, April 12, 2013EXAMINERS AMENDMENT -WRITTEN
Saturday, March 30, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, March 30, 2013NON-FINAL ACTION E-MAILED
Saturday, March 30, 2013NON-FINAL ACTION WRITTEN
Friday, March 29, 2013ASSIGNED TO EXAMINER
Thursday, January 17, 2013NOTICE OF PSEUDO MARK MAILED
Wednesday, January 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 10, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

biopharmaceuticals epirus disorders namely conditions multiple treatment oncology respiratory gastrointestinal used rheumatic